Medios AG (MEDOF) Research

Medios AG, along with its affiliated companies, operates as a wholesale supplier of specialized pharmaceutical products throughout Germany. The company's operations are divided into two main divisions: Pharmaceutical Supply and Patient-Specific Therapies. The Pharmaceutical Supply segment provides medications for critical conditions such as oncology, neurological disorders, autoimmune diseases, ophthalmological issues, infectious diseases, and hemophilia. The Patient-Specific Therapies segment focuses on creating customized medications for individual patients, often prepared for dispensing by pharmacies, and offers bespoke therapeutic solutions, including tablets with precisely tailored dosages. Established in 2016, Medios AG is headquartered in Berlin, Germany.

Market snapshot

Symbol
MEDOF
Price
$50.00
Day change
0.00%
Market cap
$324.9M
P/E ratio
22.40x
52-week range
13.64-50
Sector
Healthcare
Industry
Medical - Distribution
Next earnings
in 2 months

Peer companies

  • Cosmo Pharmaceuticals N.V. (CMOPF)
  • Craneware plc (CRWRF)
  • Evotec SE (EVOTF)
  • Kissei Pharmaceutical Co., Ltd. (KSPHF)
  • Sienna Senior Living Inc. (LWSCF)
  • H.U. Group Holdings, Inc. (MRCHF)
  • Raffles Medical Group Ltd (RAFLF)
  • Sawai Group Holdings Co., Ltd. (SWGHF)

Open Medios AG (MEDOF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.